Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: Relationship to apoptosis and differentiation

This publication has 38 references indexed in Scilit:

• Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: Preliminary studies on therapeutic efficacy and toxicity
  Proceedings of the National Academy of Sciences, 1998
• Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937)
  Differentiation, 1998
• p53-dependent Induction of Apoptosis by Proteasome Inhibitors
  Journal of Biological Chemistry, 1997
• Modulation of Protein Kinase C Activity and Calcium-Sensitive Isoform Expression in Human Myeloid Leukemia Cells by Bryostatin 1: Relationship to Differentiation and Ara-C-Induced Apoptosis
  Experimental Cell Research, 1996
• Progression of the myeloid differentiation program is dominant to transforming growth factor-beta 1-induced apoptosis in M1 myeloid leukemic cells
  Blood, 1994
• Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-d-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells
  Biochemical Pharmacology, 1994
• Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors
  Blood, 1993
• Enhancement of differentiation and cytotoxicity of leukemia cells by combinations of fluorinated pyrimidines and differentiation inducers: development of DNA double-strand breaks
  Biomedicine & Pharmacotherapy, 1992
• Two protein kinase C activators, bryostatin-1 and phorbol-12-myristate-13-acetate, have different effects on haemopoietic cell proliferation and differentiation
  Cellular Signalling, 1992
• HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis
  Clinical and Experimental Immunology, 1990